why choose us

Clinical Trials Search

Showing 10,890 of 132,366 result(s)
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)

Status: COMPLETED

Condition: Covid19

Interventions: Each participant will receive a sufficient quantity of 7-mg tablets to be taken as directed based on their weight.
The tablets are white, round,

Date: 2023-06-06

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

Status: Completed

Condition: Sars-CoV-2 Infection

Interventions: Recording (only once) of sound related to respiratory movements, coughing and voice using a mobile phone application

Date: 2023-06-06

Classical Guitar for Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: See arm;group descriptions

Date: 2023-06-06

Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents

Status: Completed

Condition: Pediatric Cancer

Interventions: "Storytelling Through Music" is a six-week expressive arts intervention.

Date: 2023-06-06

Impact of Exercise Intervention on Well-being in Shift-working Acute Care Nurses

Status: Completed

Condition: Psychological Wellness

Interventions: 12-Week Exercise intervention on mentaL, metabolic, physicaL, spiritual, social, and occupational well-being among shift-working acute care NURSE

Date: 2023-06-06

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Status: Completed

Condition: Triple Negative Breast Cancer

Interventions: Visium : Spatial transcriptomics WGS;WTS : detection of somatic mutation

Date: 2023-06-06

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

Status: ACTIVE_NOT_RECRUITING

Condition: Cardiometabolic Syndrome

Interventions: The Aegis CDM diagnostic test will be given to intervention participants to use on their patients.
The participants will receive the results of t

Date: 2023-06-06

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Status: Completed

Condition: Atopic Dermatitis Eczema

Interventions: BTLA agonist antibody

Date: 2023-06-06

Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants

Status: COMPLETED

Condition: Opioid Use Disorder

Interventions: [14C]-IDV184001AN 200 mg;~100 µCi; 15 g oral suspension

Date: 2023-06-06

GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma

Status: NOT_YET_RECRUITING

Condition: Metastatic Melanoma

Interventions: Administered orally twice daily at 400mg.

Date: 2023-06-06